Response to various ITP-specific therapies of a patient with CTP (patient 2)
| . | Duration . | Platelet count, ×109/L . | |
|---|---|---|---|
| Nadir . | Zenith . | ||
| Prednisolone | 3 mo | 11 | 140 |
| Rituximab | 4 cycles | 3 | 7 |
| SE | NA | 167 (before SE) | 445 (after SE) |
| Eltrombopag | 2 mo | 4 | 900 |
| Romiplostim | 22 mo | 1 | 2.065 |
| . | Duration . | Platelet count, ×109/L . | |
|---|---|---|---|
| Nadir . | Zenith . | ||
| Prednisolone | 3 mo | 11 | 140 |
| Rituximab | 4 cycles | 3 | 7 |
| SE | NA | 167 (before SE) | 445 (after SE) |
| Eltrombopag | 2 mo | 4 | 900 |
| Romiplostim | 22 mo | 1 | 2.065 |
NA, not applicable; SE, splenectomy.